Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
Reach Us +1-947-333-4405

GET THE APP

The Preliminary Results Of MicroRNA Gene Expression In Patients With Crimean-Congo Hemorrhagic Fever | 64935

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

The preliminary results of microRNA gene expression in patients with Crimean-Congo hemorrhagic fever

4th International Congress on Infectious Diseases

Serdal Arslan, Aynur Engin, Nil Ozbilum, Ismail Sar�?± and Mehmet Bak�?±r

Cumhuriyet University, Turkey

Posters & Accepted Abstracts: J Infect Dis Ther

DOI: 10.4172/2332-0877-C1-024

Abstract
Statement of the Problem: Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease caused by the arbovirus CCHF virus and characterized by a sudden onset of high fever, severe headache, dizziness, back and abdominal pains. The disease now occurs sporadically throughout much of Africa, Asia and Europe and results in an approximately 15% fatality rate. MicroRNAs (miRNAs) are small non-coding RNAs responsible of post transcriptional regulation of gene expression through interaction with mRNAs. They are involved in important biological processes and are often dysregulated in a variety of diseases, including cancer and infections. miRNAs are key players in virus-host interactions and viral pathogenesis. Aim: The aim of this study is to investigate micro RNA gene expression profiles in patients with CCHF using microarray at first time of the world. Methodology & Theoretical Orientation: In our study, patients with CCHF will be investigated in miRNA expression profiles using microarray analysis. The miRNA expression levels were compared between case and control populations. Blood samples were taken from CCHF patients and control. Total RNA was isolated from blood samples using miRNeasy Mini kit (Qiagen). Microarray analysis was performed using miRBase Version 21 (Agilent Technologies). Findings: Result of miRNA expression was analyzed by GeneSpring Version 3.0 bioinformatics program. It has been found that five miRNA expressions of patients with CCHF were statistically significant with regard to controls. MiR-126-3p, miR-144-5p, miR-148a- 3p were up-regulated, whereas miR-339-3p and miR-4497 was down-regulated in CCHF patients when compared within controls. This analysis revealed these five miRNAs with a fold change from 1.71 to 27.14. Conclusion & Significance: The preliminary analysis of miRNAs in CCHF revealed differential miRNA expression in infected individuals and control. The results obtained from the study will contribute to explain the role of miRNA in pathogenesis of CCHF.
Biography

Serdal Arslan is an Associate Professor in Department of Medical Biology, Faculty of Medicine at Cumhuriyet University, Turkey. He completed his PhD in Molecular Biology. His area of expertise is in Molecular Medicine. He has been working on non-coding RNAs in different diseases. He has been conducting molecular genetic studies in Crimean-Congo hemorrhagic fever disease in recent years.

Email: arserdal@yahoo.com

Top